These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 16084274)
1. Management of peripheral arterial disease in chronic kidney disease. O'Hare AM Cardiol Clin; 2005 Aug; 23(3):225-36. PubMed ID: 16084274 [TBL] [Abstract][Full Text] [Related]
2. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737 [TBL] [Abstract][Full Text] [Related]
3. Peripheral arterial disease: a guide for nephrologists. DeLoach SS; Mohler ER Clin J Am Soc Nephrol; 2007 Jul; 2(4):839-46. PubMed ID: 17699501 [TBL] [Abstract][Full Text] [Related]
4. Peripheral arterial disease in patients with stages IV and V chronic renal failure. Guerrero A; Montes R; Muñoz-Terol J; Gil-Peralta A; Toro J; Naranjo M; González-Pérez P; Martín-Herrera C; Ruiz-Fernández A Nephrol Dial Transplant; 2006 Dec; 21(12):3525-31. PubMed ID: 16940320 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation. Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357 [TBL] [Abstract][Full Text] [Related]
6. Therapy insight: peripheral arterial disease and diabetes--from pathogenesis to treatment guidelines. Mohler ER Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):151-62. PubMed ID: 17330127 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease. Blinc A; Poredos P Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482 [TBL] [Abstract][Full Text] [Related]
8. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected. Paraskevas KI; Giannoukas AD; Mikhailidis DP Ann Vasc Surg; 2009; 23(5):690-9. PubMed ID: 19747617 [TBL] [Abstract][Full Text] [Related]
15. The role of biomarkers and genetics in peripheral arterial disease. McDermott MM; Lloyd-Jones DM J Am Coll Cardiol; 2009 Sep; 54(14):1228-37. PubMed ID: 19778662 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of two coronary risk equivalents: diabetes mellitus and peripheral arterial disease]. Darius H; Trampisch HJ; Pittrow D; Allenberg JR; Haberl RL; Mahn M; Tepohl HG; Burghaus I; Diehm C Dtsch Med Wochenschr; 2008 Nov; 133(45):2317-22. PubMed ID: 18958826 [TBL] [Abstract][Full Text] [Related]
17. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence. Kanbay M; Turgut F; Covic A; Goldsmith D J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992 [TBL] [Abstract][Full Text] [Related]
18. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy. Makowsky MJ; McAlister FA; Galbraith PD; Southern DA; Ghali WA; Knudtson ML; Tsuyuki RT; Am Heart J; 2008 Feb; 155(2):348-55. PubMed ID: 18215607 [TBL] [Abstract][Full Text] [Related]
19. Peripheral arterial disease: a review of disease awareness and management. Watson K; Watson BD; Pater KS Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541 [TBL] [Abstract][Full Text] [Related]